# TcLand Expression

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/tcland-expression

- Industry: Biotechnology
- Headquarters: Nantes, France
- Website: www.tcland-expression.com
- Total disclosed funding: $12M
- Latest round: Series A (Jun 3, 2009)
- Investors on record: 4

## About

TcLand Expression SA is a France-based company that operates as a provider of gene expression biomarkers for unmet medical needs in transplantation and auto-immune diseases.

## Funding rounds

- Series A, Jun 3, 2009, $5.7M — Auriga Partners, Quest Management, Genzyme Corporation, Debiopharm Innovation Fund
- Series A, Feb 1, 2008, $5.9M — Auriga Partners, Quest Management, Genzyme Corporation, Debiopharm Innovation Fund

## Investors

- Auriga Partners (https://capitalatlas.ai/funds/auriga-partners) — Series A
- Quest Management (https://capitalatlas.ai/funds/quest-management) — Series A
- Genzyme Corporation — Series A
- Debiopharm Innovation Fund (https://capitalatlas.ai/funds/debiopharm-innovation-fund) — Series A